why is everyone taking glp 1 The promise and peril of GLP-1 agonists: What we do (and don't) know as of August 2024 What Happens When Patients Stop

On the horizon, retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously

Curr Pediatr Rep 13 , 31 (2025)

Semaglutide GLP-1 works by targeting multiple pathways in the body, including appetite regulation, calorie intake reduction, and improved metabolic function, which can cause a decrease in the fat in the belly over time

These will focus mainly on medications that are becoming available different ways of using old medications, new formulations, and new drugs in the pipeline

- Women on ACE inhibitors, ARBs, or NSAIDs concurrently these drugs raise potassium too

Additionally, the limited supply of many of these products has increasingly shifted toward use in obesity treatment, driven by profit motives, leaving many type 2 diabetes patients unable to access medications they rely upon